Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease

Background. There is evidence that genetic polymorphisms of important proinflammatory cytokines IL1α and IL6 are associated with the risk of Alzheimer’s disease (AD). In this study, we aimed to evaluate the association of IL1A -889C>T and IL6 -174G>C polymorphisms with the risk of sporadic AD...

Full description

Saved in:
Bibliographic Details
Main Authors: G. Pšemeneckienė, K. Petrikonis, D. Rastenytė
Format: Article
Language:English
Published: Vilnius University Press 2019-09-01
Series:Neurologijos seminarai
Subjects:
Online Access:https://www.journals.vu.lt/neurologijos_seminarai/article/view/27774
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593085960290304
author G. Pšemeneckienė
K. Petrikonis
D. Rastenytė
author_facet G. Pšemeneckienė
K. Petrikonis
D. Rastenytė
author_sort G. Pšemeneckienė
collection DOAJ
description Background. There is evidence that genetic polymorphisms of important proinflammatory cytokines IL1α and IL6 are associated with the risk of Alzheimer’s disease (AD). In this study, we aimed to evaluate the association of IL1A -889C>T and IL6 -174G>C polymorphisms with the risk of sporadic AD in APOE ε4 carriers and in persons without APOE risk allele. We also investigated the association of IL1A -889C>T and IL6 -174G>C polymorphisms with the rate of AD progression. Materials and methods. The study included 110 patients with sporadic AD and 115 age-and-gender-matched healthy controls (HC) without cognitive decline (Lithuanian population). Genotyping of IL1A -889C>T (rs1800587) and IL6 -174G>C (rs1800795, Intron type) was performed using real-time PCR (RT-PCR). Results. The distribution of IL1A -889C>T genotypes did not differ between APOE ε4 carriers (APOE4+: C/C – 52.9%, C/T – 41.2%, T/T – 5.9%) and APOE negative AD patients (APOE4-: C/C – 55.6%, C/T – 37.0%, T/T – 7.4%; p=0.887). IL6 -174G>C genotype frequencies in APOE4+ (G/G – 11.8%, G/C – 62.7%, C/C – 25.5%) and APOE4- (G/G – 14.8%, G/C – 61.1%, C/C – 24.1%) were also similar (p=0.898) in AD group. No significant differences of genotype frequencies in rapidly progressing AD compared to slowly progressing AD were revealed (p (IL1A -889C>T)=0.638; p (IL6 -174G>C)=0.118). Controlling by APOE4 status, the inheritance of IL1A -889C>T or IL6 -174G>C polymorphisms (dominant, overdominant, and recessive models) did not significantly alter the odds ratio for sporadic AD (p<0.05). In slowly and rapidly progressing AD groups, the inheritance of IL1A -889C>T and IL6 -174G>C polymorphisms had no significant impact on AD risk (p<0.05). Conclusions. No significant differences of IL1A -889C>T and IL6 -174G>C genotype frequencies were found either between groups according to the APOE ε4 allele possession or in patients with rapidly progressing AD compared to slowly progressing AD patients. No significant associations of IL1A -889C>T and IL6 -174G>C polymorphisms and AD risk were revealed in either APOE4 positive or APOE4 negative persons. According to our data, inheritance of IL1A -889C>T and IL6 -174G>C polymorphisms is not associated with faster progression of AD.
format Article
id doaj-art-c245ee75f8e64e1d86f1da66122f9ff6
institution Kabale University
issn 1392-3064
2424-5917
language English
publishDate 2019-09-01
publisher Vilnius University Press
record_format Article
series Neurologijos seminarai
spelling doaj-art-c245ee75f8e64e1d86f1da66122f9ff62025-01-20T18:22:57ZengVilnius University PressNeurologijos seminarai1392-30642424-59172019-09-01233(81)10.29014/ns.2019.18Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s diseaseG. Pšemeneckienė 0K. Petrikonis 1D. Rastenytė 2Lithuanian University of Health SciencesLithuanian University of Health SciencesLithuanian University of Health Sciences Background. There is evidence that genetic polymorphisms of important proinflammatory cytokines IL1α and IL6 are associated with the risk of Alzheimer’s disease (AD). In this study, we aimed to evaluate the association of IL1A -889C>T and IL6 -174G>C polymorphisms with the risk of sporadic AD in APOE ε4 carriers and in persons without APOE risk allele. We also investigated the association of IL1A -889C>T and IL6 -174G>C polymorphisms with the rate of AD progression. Materials and methods. The study included 110 patients with sporadic AD and 115 age-and-gender-matched healthy controls (HC) without cognitive decline (Lithuanian population). Genotyping of IL1A -889C>T (rs1800587) and IL6 -174G>C (rs1800795, Intron type) was performed using real-time PCR (RT-PCR). Results. The distribution of IL1A -889C>T genotypes did not differ between APOE ε4 carriers (APOE4+: C/C – 52.9%, C/T – 41.2%, T/T – 5.9%) and APOE negative AD patients (APOE4-: C/C – 55.6%, C/T – 37.0%, T/T – 7.4%; p=0.887). IL6 -174G>C genotype frequencies in APOE4+ (G/G – 11.8%, G/C – 62.7%, C/C – 25.5%) and APOE4- (G/G – 14.8%, G/C – 61.1%, C/C – 24.1%) were also similar (p=0.898) in AD group. No significant differences of genotype frequencies in rapidly progressing AD compared to slowly progressing AD were revealed (p (IL1A -889C>T)=0.638; p (IL6 -174G>C)=0.118). Controlling by APOE4 status, the inheritance of IL1A -889C>T or IL6 -174G>C polymorphisms (dominant, overdominant, and recessive models) did not significantly alter the odds ratio for sporadic AD (p<0.05). In slowly and rapidly progressing AD groups, the inheritance of IL1A -889C>T and IL6 -174G>C polymorphisms had no significant impact on AD risk (p<0.05). Conclusions. No significant differences of IL1A -889C>T and IL6 -174G>C genotype frequencies were found either between groups according to the APOE ε4 allele possession or in patients with rapidly progressing AD compared to slowly progressing AD patients. No significant associations of IL1A -889C>T and IL6 -174G>C polymorphisms and AD risk were revealed in either APOE4 positive or APOE4 negative persons. According to our data, inheritance of IL1A -889C>T and IL6 -174G>C polymorphisms is not associated with faster progression of AD. https://www.journals.vu.lt/neurologijos_seminarai/article/view/27774Alzheimer’s diseaseIL1AIL6polymorphismAPOE
spellingShingle G. Pšemeneckienė
K. Petrikonis
D. Rastenytė
Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease
Neurologijos seminarai
Alzheimer’s disease
IL1A
IL6
polymorphism
APOE
title Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease
title_full Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease
title_fullStr Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease
title_full_unstemmed Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease
title_short Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease
title_sort interleukin il1a and il6 gene polymorphism search for association with apoe genotype and clinical course of sporadic alzheimer s disease
topic Alzheimer’s disease
IL1A
IL6
polymorphism
APOE
url https://www.journals.vu.lt/neurologijos_seminarai/article/view/27774
work_keys_str_mv AT gpsemeneckiene interleukinil1aandil6genepolymorphismsearchforassociationwithapoegenotypeandclinicalcourseofsporadicalzheimersdisease
AT kpetrikonis interleukinil1aandil6genepolymorphismsearchforassociationwithapoegenotypeandclinicalcourseofsporadicalzheimersdisease
AT drastenyte interleukinil1aandil6genepolymorphismsearchforassociationwithapoegenotypeandclinicalcourseofsporadicalzheimersdisease